AFCD-1.42 / S7 Vault
A chiral screen. The claim: it tells a eutomer from its distomer, the two mirror-image forms of a chiral molecule. The methods are withheld. This page is a funding and license door.
The claim
AFCD-1.42 is an instrument concept recorded on 22 April 2026 in Belize. It's described as a chiral screen that separates a eutomer (the more active mirror-image form) from its distomer (the less active form). That claim is all this page makes.
Proof class
Internal instrument record, 22 Apr 2026 · independent validation pending
No third party has validated it yet. Funding and license proceeds go first toward an independent validation study.
What this is not
- Not a diagnostic, clinical, or medical device, and it makes no health or treatment claim.
- Not a forensic or evidentiary tool, and not offered for legal proceedings.
- Not a tool for identifying controlled or regulated substances. We don't accept such materials.
What stays sealed
- The measurement method, sample set, and analysis are withheld.
- Internal records and encodings are withheld.
- Disclosure happens only under a signed NDA or license. See Sealed License.
Three doors
Capped briefing
- Redacted briefing on the 22 Apr 2026 record
- Outputs only, no method
- One session per organisation, 30 minutes
- Recording not provided
Screening job or watch list
- Watch list $79/mo: Vault updates, validation progress, priority job slots
- Screening job: by quote, after a scope review
- Lawful, non-regulated research materials only
- Results are research-grade and uncertified
We review each job request first and may decline it. Nothing is invoiced until the scope is agreed in writing.
Fund validation or license
- NDA data-room access: $2,500, credited to a license
- Validation sponsor: from $25,000, funds independent validation
- Field license: by quote
- Mutual NDA before any disclosure
This is not an offer of securities. Any investment or license terms exist only in a separate signed agreement.
Also see Agent Rentals · The Vault